Home > The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.

Lutge, Elizabeth L and Gray, Andy and Siegfried, Nandi [The Cochrane Library] . (2013) The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews, 4 Art. No.: CD005175. DOI: 10.1002/14651858.CD005175.pub3

URL: http://onlinelibrary.wiley.com/doi/10.1002/1465185...

The use of cannabis (marijuana), its active ingredient or synthetic forms such as dronabinol has been advocated in patients with HIV/AIDS, in order to improve the appetite, promote weight gain and lift mood. Dronabinol has been registered for the treatment of AIDS-associated anorexia in some countries. However, the evidence for positive effects in patients with HIV/AIDS is limited, and some of that which exists may be subject to the effects of bias. Those studies that have been performed have included small numbers of participants and have focused on short-term effects. Longer-term data, and data showing a benefit in terms of survival, are lacking. There are insufficient data available at present to justify wide-ranging changes to the current regulatory status of cannabis or synthetic cannabinoids.


Item Type:Evidence resource
Publication Type:Review
Drug Type:Cannabis
Intervention Type:AOD disorder drug therapy, AOD disorder harm reduction
Source:The Cochrane Library
Date:2013
Publisher:John Wiley & Sons, Ltd
Place of Publication:London
Volume:4
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:G Health and disease > Disorder by cause > Communicable disease > Acquired immunodeficiency syndrome (AIDS)
G Health and disease > State of health > Physical health
G Health and disease > Disorder by cause > Communicable disease > HIV infection
B Drugs and alcohol substances > Cannabis / Marijuana

Repository Staff Only: item control page